Cara Therapeutics (CARA) Flagged As Strong On High Volume

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Cara Therapeutics ( CARA) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Cara Therapeutics as such a stock due to the following factors:

  • CARA has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $4.5 million.
  • CARA has traded 67,471 shares today.
  • CARA is trading at 3.99 times the normal volume for the stock at this time of day.
  • CARA is trading at a new high 3.01% above yesterday's close.

'Strong on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as M&A events, material stock news, analyst upgrades, insider buying, buying from 'superinvestors,' or that hedge funds and momentum traders are piling into a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize. In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in CARA with the Ticky from Trade-Ideas. See the FREE profile for CARA NOW at Trade-Ideas

More details on CARA:

If you liked this article you might like

Trump's FDA: A Friendlier Biotech Sheriff

Mattel, Mazor, Raytheon: 'Mad Money' Lightning Round (7/10/17)

These Stocks Are Changing Directions

Watching the Dip Buyers This Morning